EP3914257
COMBINATION OF A BCL-2/BCL-XL INHIBITOR WITH OSIMERTINIB
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
1.4.2021EP published:
27.12.2023EP application number:
21754882.5
EPO information:
European Patent Register
Max expiry date:
31.3.2041
Title in English:
COMBINATION OF A BCL-2/BCL-XL INHIBITOR WITH OSIMERTINIBLanguage of the patent:
English
Timeline
Today
1.4.2021EP application
27.12.2023EP Publication
Owner
Name:
Ascentage Pharma (Suzhou) Co., Ltd.Address:
Unit 701, Building B7, 218 Xinghu Street Suzhou Industrial Park, Suzhou, Jiangsu 215000, CN
Name:
Ascentage Pharma Group Corp LimitedAddress:
9/F., Wah Yuen Building 149 Queen's Road Central, Hong Kong 999077, CN
Inventor
Name:
ZHAI, YifanAddress:
Jiangsu 215000, CN
Name:
YANG, DajunAddress:
Jiangsu 215000, CN
Priority
Number:
PCT/CN2020/084145Date:
10.4.2020Country:
WO
Number:
202110344288Date:
31.3.2021Country:
CN
Classification
Categories:
A61K 31/675, A61P 35/04, A61P 35/00, A61K 45/06, A61K 31/519, A61K 31/506, A61K 31/496, A61K 31/337, A61K 31/407